Correlation Between Annovis Bio and CureVac NV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annovis Bio and CureVac NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annovis Bio and CureVac NV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annovis Bio and CureVac NV, you can compare the effects of market volatilities on Annovis Bio and CureVac NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annovis Bio with a short position of CureVac NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annovis Bio and CureVac NV.

Diversification Opportunities for Annovis Bio and CureVac NV

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Annovis and CureVac is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Annovis Bio and CureVac NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CureVac NV and Annovis Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annovis Bio are associated (or correlated) with CureVac NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CureVac NV has no effect on the direction of Annovis Bio i.e., Annovis Bio and CureVac NV go up and down completely randomly.

Pair Corralation between Annovis Bio and CureVac NV

Given the investment horizon of 90 days Annovis Bio is expected to generate 1.76 times more return on investment than CureVac NV. However, Annovis Bio is 1.76 times more volatile than CureVac NV. It trades about 0.03 of its potential returns per unit of risk. CureVac NV is currently generating about -0.02 per unit of risk. If you would invest  1,157  in Annovis Bio on August 30, 2024 and sell it today you would lose (503.00) from holding Annovis Bio or give up 43.47% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Annovis Bio  vs.  CureVac NV

 Performance 
       Timeline  
Annovis Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CureVac NV is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Annovis Bio and CureVac NV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annovis Bio and CureVac NV

The main advantage of trading using opposite Annovis Bio and CureVac NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annovis Bio position performs unexpectedly, CureVac NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CureVac NV will offset losses from the drop in CureVac NV's long position.
The idea behind Annovis Bio and CureVac NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk